A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms
Status:
NOT_YET_RECRUITING
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
A Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1195E CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms
Phase:
PHASE1
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital, China